Literature DB >> 12576582

Population structure analysis of Burkholderia cepacia genomovar III: varying degrees of genetic recombination characterize major clonal complexes.

Tom Coenye1, John J LiPuma.   

Abstract

Infection with bacterial species belonging to the Burkholderia cepacia complex contribute significantly to morbidity and mortality in persons with cystic fibrosis (CF). The majority of isolates recovered from CF patients belong to B. cepacia genomovar III and several distinct 'epidemic' strains have been described. This study examined the population structure of B. cepacia genomovar III by using multilocus restriction typing, indexing allelic variation at five chromosomal genes by restriction analysis of PCR-amplified genes. A collection of 375 isolates, recovered from CF and non-CF patients and natural environments in North America, Europe and Australia, was examined. Among these isolates 144 different restriction types were found. Overall, the population is at linkage disequilibrium, indicating that it has a clonal structure. The majority (86.7 %) of restriction types grouped into three major clonal complexes, comprising the epidemic ET12, PHDC and Midwest clonal lineages. The analysis indicates that these complexes are geographically widespread and demonstrate varying degrees of genetic recombination. These differences in population structure among major clonal complexes within the same species are likely related to differences in evolutionary history and ecology. The observation that genetic recombination is frequent within some B. cepacia genomovar III populations has important implications for the biotechnological use of B. cepacia complex species.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12576582     DOI: 10.1099/mic.0.25850-0

Source DB:  PubMed          Journal:  Microbiology (Reading)        ISSN: 1350-0872            Impact factor:   2.777


  23 in total

1.  Correlation of wbiI genotype, serotype, and isolate source within species of the Burkholderia cepacia complex.

Authors:  Arlene D Vinion-Dubiel; Theodore Spilker; Charles R Dean; Henri Monteil; John J LiPuma; Joanna B Goldberg
Journal:  J Clin Microbiol       Date:  2004-09       Impact factor: 5.948

2.  Efficacy of bacteriophage therapy in a model of Burkholderia cenocepacia pulmonary infection.

Authors:  Lisa A Carmody; Jason J Gill; Elizabeth J Summer; Uma S Sajjan; Carlos F Gonzalez; Ryland F Young; John J LiPuma
Journal:  J Infect Dis       Date:  2010-01-15       Impact factor: 5.226

3.  Transmission of Burkholderia cepacia complex: evidence for new epidemic clones infecting cystic fibrosis patients in Italy.

Authors:  S Campana; G Taccetti; N Ravenni; F Favari; L Cariani; A Sciacca; D Savoia; A Collura; E Fiscarelli; G De Intinis; M Busetti; A Cipolloni; A d'Aprile; E Provenzano; I Collebrusco; P Frontini; G Stassi; M Trancassini; D Tovagliari; A Lavitola; C J Doherty; T Coenye; J R W Govan; P Vandamme
Journal:  J Clin Microbiol       Date:  2005-10       Impact factor: 5.948

4.  The Rate and Molecular Spectrum of Spontaneous Mutations in the GC-Rich Multichromosome Genome of Burkholderia cenocepacia.

Authors:  Marcus M Dillon; Way Sung; Michael Lynch; Vaughn S Cooper
Journal:  Genetics       Date:  2015-05-12       Impact factor: 4.562

5.  Burkholderia cenocepacia J2315 escapes to the cytosol and actively subverts autophagy in human macrophages.

Authors:  Souhaila Al-Khodor; Kimberly Marshall-Batty; Vinod Nair; Li Ding; David E Greenberg; Iain D C Fraser
Journal:  Cell Microbiol       Date:  2013-11-06       Impact factor: 3.715

6.  The Fitness Effects of Spontaneous Mutations Nearly Unseen by Selection in a Bacterium with Multiple Chromosomes.

Authors:  Marcus M Dillon; Vaughn S Cooper
Journal:  Genetics       Date:  2016-09-26       Impact factor: 4.562

7.  In vitro activities of a novel nanoemulsion against Burkholderia and other multidrug-resistant cystic fibrosis-associated bacterial species.

Authors:  John J LiPuma; Sivaprakash Rathinavelu; Bridget K Foster; Jordan C Keoleian; Paul E Makidon; Linda M Kalikin; James R Baker
Journal:  Antimicrob Agents Chemother       Date:  2008-10-27       Impact factor: 5.191

Review 8.  Infection control in cystic fibrosis.

Authors:  Lisa Saiman; Jane Siegel
Journal:  Clin Microbiol Rev       Date:  2004-01       Impact factor: 26.132

9.  Clonality and diversity of the fish pathogen Lactococcus garvieae in Mediterranean countries.

Authors:  Marina Eyngor; Amir Zlotkin; Claudio Ghittino; Marino Prearo; Diane-Gaëlle Douet; Stefan Chilmonczyk; Avi Eldar
Journal:  Appl Environ Microbiol       Date:  2004-09       Impact factor: 4.792

10.  Susceptibility of Caenorhabditis elegans to Burkholderia infection depends on prior diet and secreted bacterial attractants.

Authors:  Vaughn S Cooper; Wendy A Carlson; John J Lipuma
Journal:  PLoS One       Date:  2009-11-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.